查詢結果分析
相關文獻
- Bortezomib用於多發性骨髓瘤之治療
- Bortezomib治療多發性骨髓瘤之新藥
- 鼻腔髓外漿細胞瘤--病例報告
- Multiple Myeloma Presenting with a Paraspinal Tumor and Malignant Effusion: Case Report
- Immunoglobulin D Multiple Myeloma: A Case Report
- 多發性骨髓瘤--病例報告
- Multiple Myeloma with Myelomatous Pleural Effusion--A Case Report
- 當前多發性骨髓瘤治療與護理趨勢之探討
- Immunoglobulin D Multiple Myeloma
- Multiple Myeloma Associated with Extramedullary Plasmacytoma Causing Nerve Root Compression:A Case Report
頁籤選單縮合
題名 | Bortezomib用於多發性骨髓瘤之治療=Bortezomib for Multiple Myeloma |
---|---|
作者 | 徐秉裕; 王慧瑜; Hsu, Ping-yu; Wang, Hue-yu; |
期刊 | 藥學雜誌 |
出版日期 | 20130300 |
卷期 | 29:1=114 2013.03[民102.03] |
頁次 | 頁76-80 |
分類號 | 418.31 |
語文 | chi |
關鍵詞 | 多發性骨髓瘤; 蛋白酶體抑制劑; 抗癌藥品; Bortezomib; Multiple myeloma; Proteasome inhibitor; |
中文摘要 | 早期最常用來治療多發性骨髓瘤的化學治療標準組合為烷基化劑 melphalan 合併類固醇藥品 prednisolone 使用,但往往使用一段時間後會有抗藥性產生而又再次復發,bortezomib 是一種 protesome 抑制劑,可以阻斷骨髓瘤細胞中很重要的訊息傳遞路徑,因此可以抑制癌細胞生長而大大增加了治療的機會。 |
英文摘要 | Melphalan and prednisolone has been a standard treatment of multiple myeloma since 1960, but also has induced more resistant relapse. Bortezomib is a proteasome inhibitor. This drug is thought to inhibit many proteins that cancer cells need to survive and multiply. It has been shown to have anti-tumor activity in malignancies. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。